Syngene International opens COVID-19 RT-PCR testing centre

Syngene International Ltd, a global research and development services company, today announced the opening of COVID-19 testing laboratory at its Bengaluru site. The company used its experience in clinical trial management, human clinical sample testing procedures, molecular biology and viral testing to gain the additional approvals, including ICMR approval, necessary to open the facility to support hospitals in the city. At present, there are 277 government laboratories approved and supported by ICMR and 16 private labs for testing Coronavirus, including six in Bengaluru.

Syngene has repurposed one of its laboratories to conduct RT-PCR tests. A dedicated team of scientists has been trained to perform these tests as per the guidelines prescribed by national and global regulatory authorities. Necessary processes have been established for safe handling of the samples and testing kits have been sourced & validated.

Syngene is also working to supply reagents, primers and probes for COVID-19 diagnostic testing to clients, as well as working on research projects related to vaccine development, which could represent a longer-term solution for fighting Coronavirus pandemic.

The stock closed at 309, down by 0.18 per cent or Rs 0.55 per share. The intraday high is Rs 323.50 and intraday low is Rs 307.75. The 52-week high is Rs 368.10 and 52-week low is Rs 201.65 on BSE.